Wypełniacze skórne
TEOSYAL pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
Oznakowanie CE
SKU 11161
·
GTIN 0107640173232261
Teosyal RHA 1
Dostępny
Objętość
2 x 1 mL
Laboratorium
Teoxane
Pochodzenie
Szwajcaria
Wskazanie
Superficial fine wrinkle correction and broad facial indication range including lips
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.
TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.
Najważniejsze zalety: Teosyal RHA 1
- Corrects superficial fine wrinkles, skin cracks and depressions
- Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
- Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
- Degree of cross-linking below 5%, with residual BDDE below 1 ppm
- Mean molecular weight above 1 million Dalton, of non-animal origin
- Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
- Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
- Estimated duration of at least 12 months
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Superficial fine wrinkles, skin cracks and depressions
- Enhancement of skin quality and correction of withered skin marked by signs of ageing
Zastosowanie profesjonalne
TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.
Obszary zabiegowe
- Perioral region: perioral rhytids, lips including the philtrum, oral commissures
- Upper face: forehead lines
- Periorbital region: crow's feet, tear trough, eyebrows
- Midface: smiling lines and accordion lines
- Neck lines
- Face, neck and décolleté, for skin quality
Profil pacjenta
For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.
Jak działa Teosyal RHA 1
TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty TEOSYAL od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.
Najczęściej zadawane pytania
How does TEOSYAL RHA 1 differ from the rest of the RHA line?
Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.
How long does TEOSYAL RHA 1 last?
The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
Więcej od Teoxane
TEOXANE pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
TEOXANE Produkty
Zobacz wszystkie 18![Teoxane [3D] Lip](/web/image/product.template/13487/image_512)
Kosmetyki estetyczne
Alternatywy dla kliniki
/ Ostatnio oglądane
Kontynuuj przeglądanie
Teosyal RHA 1
Dostępny
Oznakowanie CE
TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.
Najważniejsze zalety: Teosyal RHA 1
- Corrects superficial fine wrinkles, skin cracks and depressions
- Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
- Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
- Degree of cross-linking below 5%, with residual BDDE below 1 ppm
- Mean molecular weight above 1 million Dalton, of non-animal origin
- Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
- Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
- Estimated duration of at least 12 months
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Superficial fine wrinkles, skin cracks and depressions
- Enhancement of skin quality and correction of withered skin marked by signs of ageing
Zastosowanie profesjonalne
TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.
Obszary zabiegowe
- Perioral region: perioral rhytids, lips including the philtrum, oral commissures
- Upper face: forehead lines
- Periorbital region: crow's feet, tear trough, eyebrows
- Midface: smiling lines and accordion lines
- Neck lines
- Face, neck and décolleté, for skin quality
Profil pacjenta
For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.
Jak działa Teosyal RHA 1
TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty TEOSYAL z pełną identyfikowalnością partii, produktami z oznakowaniem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.
Najczęściej zadawane pytania
How does TEOSYAL RHA 1 differ from the rest of the RHA line?
Concentration and placement. RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. RHA 2 and RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.
How long does TEOSYAL RHA 1 last?
The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.
Więcej od Teoxane
Zobacz laboratorium →* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).